Found 5 matching trials
Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
PHASE2The purpose of this multi-center,single arm,phase Ⅱ clinical trail is to de...
Status
Active Not Recruiting
Location
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma
PHASE2Extranodal NK/T-cell lymphoma is a rare and highly aggressive subtype of no...
Location
Sun Yat-sen Universitiy Cancer Center
Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma
NAThis is an open-label, single-arm, multi-center Phase II clinical trial eva...
Location
Sun Yat-sen University Cancer Center
Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma
PHASE2This is a single-arm phase 2 study designed to evaluate the safety and effi...
Location
Peking Union Medical College Hospital
Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma
PHASE2Extranodal NK/T-cell lymphoma, nasal type (NKTCL) is a common malignant tum...
Location
Cancer Hospital of Fujian Province